Scinovex
articleTop 1% cited

VEGF-dependent plasticity of fenestrated capillaries in the normal adult microvasculature

American Journal of Physiology-Heart and Circulatory Physiology · 2005 · Vol. 290(2) · pp. H560–H576

Abstract

Unlike during development, blood vessels in the adult are generally thought not to require VEGF for normal function. However, VEGF is a survival factor for many tumor vessels, and there are clues that some normal blood vessels may also depend on VEGF. In this study, we sought to identify which, if any, vascular beds in adult mice depend on VEGF for survival. Mice were treated with a small-molecule VEGF receptor (VEGFR) tyrosine kinase inhibitor or soluble VEGFRs for 1-3 wk. Blood vessels were assessed using immunohistochemistry or scanning or transmission electron microscopy. In a study of 17 normal organs after VEGF inhibition, we found significant capillary regression in pancreatic islets, thyroid, adrenal cortex, pituitary, choroid plexus, small-intestinal villi, and epididymal adipose tissue. The amount of regression was dose dependent and varied from organ to organ, with a maximum of 68% in thyroid, but was less in normal organs than in tumors in RIP-Tag2-transgenic mice or in Lewis lung carcinoma. VEGF-dependent capillaries were fenestrated, expressed high levels of both VEGFR-2 and VEGFR-3, and had normal pericyte coverage. Surviving capillaries in affected organs had fewer fenestrations and less VEGFR expression. All mice appeared healthy, but distinct physiological changes, including more efficient blood glucose handling, accompanied some regimens of VEGF inhibition. Strikingly, most capillaries in the thyroid grew back within 2 wk after cessation of treatment for 1 wk. Our findings of VEGF dependency of normal fenestrated capillaries and rapid regrowth after regression demonstrate the plasticity of the adult microvasculature.

Cancer, Hypoxia, and MetabolismAngiogenesis and VEGF in CancerCancer Cells and MetastasisPericyteEndocrinologyVascular endothelial growth factorInternal medicineImmunohistochemistryBiologyPathologyVascular endothelial growth factor ABlood vesselMedicine

MeSH terms

AxitinibAgingAnimalsBlood PressureCapillariesGlucose Tolerance TestHeartImidazolesIndazolesIslets of LangerhansKidneyMice, Inbred C57BLMice, TransgenicNeoplasm TransplantationPancreatic Neoplasms

Funding

  • Pfizer
  • Regeneron Pharmaceuticals
  • Ministerio de Economía y Competitividad
  • University of California, San Francisco
Citations
768
FWCI
17.78
field-weighted impact
References
75
Percentile
99%
vs. same field & year
Citations per year
Cited by
Vascular endothelial growth factors and vascular permeability
Cardiovascular Research · 2010 · 508 citations
Resistance Mechanisms to Anti-angiogenic Therapies in Cancer
Frontiers in Oncology · 2020 · 375 citations
Glomerular endothelial cell fenestrations: an integral component of the glomerular filtration barrier
American Journal of Physiology-Renal Physiology · 2009 · 342 citations
Mechanisms of adverse effects of anti-VEGF therapy for cancer
British Journal of Cancer · 2007 · 967 citations
VEGF receptor signalling ? in control of vascular function
Nature Reviews Molecular Cell Biology · 2006 · 3,054 citations
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.